Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA Study.
Clinical cancer research : an official journal of the American Association for Cancer Research, 2026 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume:
- Publication Date: 2026
- Doi Number: 10.1158/1078-0432.ccr-25-4523
- Journal Name: Clinical cancer research : an official journal of the American Association for Cancer Research
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
- Istanbul University-Cerrahpasa Affiliated: No